A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors

Update Il y a 4 ans
Reference: NCT01731925

Woman and Man

Extract

Sunitinib may provide an opportunity for a novel therapeutic strategy for the treatment of subjects with neuroendocrine tumors.


Inclusion criteria

  • Carcinoid Tumors

Links